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It is the responsibility of the marketing authorization holder to assure that the
safety and integrity of the medicinal products is not jeopardized during any
phase of the manufacturing process, including transportation. In the last resort it
is the marketing authorization holder´s decision how the transportation of
medicinal products is controlled and safe and good quality products provided to
the patiens. Transportation of medicinal products in European Union area is
regulated by EU Good distribution Practise (GDP) guidelines.
There are different characteristics for different modes of transportation. While
the air freight is most often the fastest mode of transportation, it is also most
vulnerable for temperature excursions during loading and unloading the
aircraft. The road transportation can in best case provide swift door to door
delivery, in worst case the road transportation can be time consuming with
many different intermediate storaging locations and many loading phases. Road
transportation is also the riskiest mode of transportation in matter of crime. In
general, the cargo is in danger whenever the vehicle is not moving. While sea
freight is the slowest mode of transportation, in some cases it can be suitable
for use. With sea freight big amounts of cargo can be transported
simultaneously and rather safely even very long distances. Both air and sea
freight require additional mode of transportation from and to airport and port.
This is called multimodal transportation.
Ultimately  the  decision  of  the  mode  of  transportation  is  a  compromise  with
pros and cons from the different modes of transportation. Some of the risks
related to transportation process can be mitigated with the proper risk
management. One risk management tool is risk assessment. In case of
transportation, risk assessment provides a wide look of the whole transportation
chain.
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Tiivistelmä/Referat – Abstract
Myyntiluvan haltijan vastuu on varmistaa, ettei lääkevalmisteiden turvallisuus tai
koskemattomuus vaarannu missään valmistusketjun vaiheessa, mukaanlukien
lääkevalmisteiden kuljetuksen aikana.
Viimekädessä myyntiluvan haltija on vastuussa siitä miten lääkevalmisteiden
kuljetusta kontrolloidaan, jotta potilaille voidaan tarjota turvallisia ja laadukkaita
lääkevalmisteita. Euroopan Unionin alueella lääkkeiden kuljetuksen
viranomaisvaatimukset on säädetty lääkkeiden hyvät jakelutavat (GDP) -ohjeistossa.
Eri kuljetusmuodoilla on kaikilla omanlaisensa ominaispiirteet. Siinä missä lentorahti
on usein nopein kuljetusmuoto, se on erittäin altis lämpötilan vaihteluille lentokoneen
lastaus- ja purkuvaiheissa. Maantiekuljetus voi parhaassa tapauksessa olla nopea
ovelta- ovelle kuljetus, mutta pahimmassa tapauksessa kuljetukseen kuluu aikaa ja se
voi sisältää useita kuorman lastauksia ja purkuja eri välivarastoihin. Maantikuljetus on
myös kuljetusmuodoista kaikkein riskialttein rikoksille. Yleisesti voidaan sanoa, että
maantiekuljetuksen lasti on vaarassa silloin kun ajoneuvo ei liiku. Vaikka merirahti on
hitain kuljetusmuoto, joissain tapauksissa se voi olla tarkoitukseen parhaiten sopiva
Hitaudesta huolitatta,  meriteitse saadaan kuljetettua samanaikaisesti suuria
tavaramääriä suhteellisen turvallisesti pitkiäkin välimatkoja. Sekä meri- että
lentorahdit vaativat toisenlaisen kuljeutusmuodon käyttöä satamasta tai lentokentältä
kohteeseen. Täytä kutsutaan monimuoto-kuljetukseksi.
Lopulta päätös kuljetusmuodosta on kompromissi eri kuljetusmuotojen hyvien ja
huonojen puolien välillä. Joitakin kuljetukseen liittyviä riskejä voidaan pienentää
kunnollisella riskien hallinnalla. Yksi riskien hallinnan työkalu on riskiarvio.
Kuljetusten riskiarvio antaa kattavan kuvan koko kuljetusketjusta.
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11 INTRODUCTION
Global supply chains of pharmaceutical products are in many cases very
complex. Numerous of variable events are possible during the transportation of
medicinal products. The risk managements processes of the pharmaceutical
company has the key role in assuring the safety and quality of the products. Even
though the authority quidelines set the minimum requirements for assuring the
safety and the quality of the medicinal products,  it should be the company´s top
priority anyway.
Eversince the  European Comission published the Good Distribution Practice
guideline in 2013, the transportation of medicinal products have gained more
attention in the industry. Since 2013 11 wholesalers have lost their wholesale
license due to non compliance with the current EU GDP (Eudra GMDP).
The  aim  of  this  project  was  to  conduct  a  risk  assessment  of  transportation  of
medicinal products for company´s use. Along with the risk assessment project, a
literature review of the variables affecting transportation was compiled.
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The transportation chains of medicinal products are complex, including multiple
different outsourced activities in transportation companies, multiple different
transportation routes, variance in modes of transportation and changes in
seasonal weather conditions in different parts of the world (EU Good
Manufacturing Practice, Annex 15, 2015). This complexity exposes the global
supply chains for theft (van Diest et al., 2017). Theft of pharmaceutical cargo
endangers the safety and integrity of the products, but it may also jeopardize the
patient safety by causing stock-out situations in the market. Vast majority of the
counterfeit or falcified medicinal products originate from the legal supply chain
(European Comission, 2011). Medicinal products can be stolen during legal
supply chain, modified or falcified by the criminals and re-entered to legal
supply chain with falcified documentation and unauthorized wholesaler (Italian
Medicine Agency, 2015). Despite the complexity of the supply chain,
transportation of medicinal products should be arranged so that quality and
integrity of the product is not compromised (EU Good Distribution Practice,
Chapter 9, 2013).
2.1 Transportation of medicinal products - Authority requirements
There are many regulations for transportation of pharmaceutical products
depending on the manufacturing country and / or distribution territory (“Good
Distribution Practice “ European Medicine Agency Reference: 14.4.2018).  Just
to name few, transportation of pharmaceutical products is regulated by EMA
(European Comission Good Distribution Practice, 2013), World Health
Organization (WHO Annex 5, Good Distribution Practice for pharmaceutical
products, 2010) and United States Pharmacopeia (USP Good storage and
Distribution practices for drug products, 2018). The regulations set minimum
standards for transportation of medicinal products (“Good Distribution Practice “
European Medicine Agency Reference: 14.4.2018). The content of the three
regulations is the same, transportation of the medicinal products should be
3arranged in a such way that is does not compromise the quality or the safety of
the product (European Comission, 2013; WHO 2010; USP). All three
regulations also require that modes of transportation, transportation routes and
the equipment used in the transportation should be suitable for use. The different
variables during the mode of transportation should also be evaluated carefully,
when making decisions of the modes of transportation or transportation route for
each  product.  Unlike  EU  GDP,  both  USP  and  WHO  Annex  5  require  risk
evaluation in the case of using dry ice on the transportation of medicinal
products. Currently only WHO Annex 5 requires drivers to identify themselves
before loading the vehicles. Continuous monitoring of the transportation
conditions is required unless justified, as per EU GDP by risk assessment of the
transportation route, or as per USP by stability data of the product.
European Medicine Agency Good Distribution Practice set the minimum
requirements for transportation of pharmaceutical products in Europe (“Good
Distribution Practice “ European Medicine Agency Reference: 14.4.2018). EU
GDP requirements for transportation are presented in Table 1.
4Table 1: EU GDP requirements for transportation of medicinal products (EU
GDP, 2013)
General requirements “Risk based approach should be utilized when
planning transportation”
“Delivery route risk assessment to be conducted,
for determining the need of temperature control”
“Deliveries can be made only to address
stated in the delivery  note”
Vehicles “Vehicles must be suitable for use or procedure
should be to ensure that quality of the product is
not compromised.”
“Written maintenance plan should be available
for vehicle and equipment”
“Equipment for temperature control should be
maintained and calibrated at least once a year”
Temperature: “Labelled storage conditions should be
maintained during transportation”
“Process should be available for investigation
and handling of temperature excursions”
In addition to GDP chapter 9 (Transportation) requirements, there are also other
chapters  that  most  often  have  effect  on  transportation  such  as  Quality  System,
and Outsourced activities (EU GDP, 2013). For pharmaceutical product
manufacturers in EU, the mandatory guideline to follow is the EU Good
Manufacturing Practice (EU GMP 2010).
52.2 Authority requirements – non compliance
Since 2013, two pharmaceutical wholesalers have lost their wholesale license
due to lack of compliance in transportation related issues (Eudra GMDP,
noncompliance Reference 14.4.2018). Transportation related issues are also
causing many major deficiencies in GDP inspections (Brown et al., 2017). In
2016, transportation related issues were the second biggest group with 13% of
all major deficiencies given by MHRA GDP inspectors.  When looked more
closely into transportation related deficiencies, transportation itself is the biggest
cause for deficiencies, while significantly lower amount of deficiencies were
related to products requiring special conditions. Justifications for major
deficienciens are presented in Table 2.
6Table 2 Major deficiencies on transportation related topics in MHRA GDP
inspections in 2016 (Brown et al., 2017)
Deficiensy
“There was inadequate reassurance that a robust process was in place
assessing the need of temperature controls for ambient storage medicinal
products across the full range of the company’s transport arrangements,
including third party distribution services”
“The site utilized uncontrolled ambient transportation for customer delivery
with no risk assessment or definition of responsibilities with customers”
“Uncalibrated equipment was being utilized to monitor the temperature during
transportation.”
“Risk assessment identifying the need for temperature controls for the
company´s own transportation arrangements lacked detail and contained
erroneous assumptions concerning UK climatic conditions.”
“It could not be demonstrated that ambient medicinal products had been
shipped in a manner to ensure temperature conditions are maintained within
acceptable limits during the entire journey.”
 2.3 Risk assessment(s) of transportation
As required  by  EU GMP Annex 15,  risk  assessment  of  transportation  must  be
done (EU GMP Annex 15, 2015).  However, the annex states, risk evaluation
should not be limited to risks, which are continuously under control or are being
monitored, but the risk evaluation should be extended to other risks as well. The
number of risks related to transportation is limitless, for example; customs
related issues, theft, product or packaging related risks, duration of the
transportation, temperature control, value of the goods, vibration during the
transportation, patient safety related risks etc. (Spiggelkötter, 2014).
Risk assessment process contains three parts: risk identification, risk analysis
and risk evaluation (International Council for Harmonization (ICH) Q9, 2006).
The process starts with risk identification. There are different tools available to
assist in the risk identification process, for example brainstorming,  what if –
7analysis, mind mapping, fish bone diagram or whatever helps to identify the
risks related to topic (Jenkins et al., 2010).
Once risks have been identified the risk management tools are used for
analyzing and evaluating the effects of the risks (ICH Q9, 2006). Useful tools for
risk  analysis  are  for  example  Fault  Tree  Analysis  (FTA),  Hazard  Analysis  and
Critical  Control  Points  (HACCP)  or  Failure  Modes  Effect  Analysis  (FMEA)
(Jenkins et al., 2010).  FTA is a useful tool but requires thorough process
understanding. Because FTA analysis gives a visual map of different failures, it
is a good tool to increase process understanding. However, it can be time
consuming even though focus is quite narrow. The fault tree analysis is designed
for identifying the root cause(s) of the unwanted event (Alverbro et al. 2010).
The  results  of  the  FTA analysis  can  be  qualitative  or  quantitative.  Example  of
the fault tree analysis diagram (Figure 1.).
Figure 1. Fault tree analysis
8HACCP is a combination tool with risk assessment and risk control features
(Jenkins et al., 2010). HACCP starts with drawing detailed process flow, hazard
(causing harm to product) identification and analyze if reduction or elimination
of the risk is needed. Critical points of the process are then identified and target
limits for critical levels set. Process performance at the critical points should be
monitored and corrective and preventive actions put into operation. HACCP is a
good tool for increasing process understanding, but it can be too heavy for other
purposes. FMEA is easy tool and as output of the analysis gives a clear
indication  of  the  risk  severity  as  Risk  Priority  Number  (RPN).  FMEA is  often
used to prevent unwanted events from happening (Alverbro et al., 2010).  In the
FMEA, each risk evaluated by its severity, occurrence and detectability (Jenkins
et al., 2010).  Final RPN scoring is result of multiplying severity, occurrence and
detectability. In the risk analysis phase, the identified risks are given a
qualitative description for example low, medium or high risk. Risk evaluation
process decided based on previous identification and analysis phases, whether
the risk is accepted as such or it should be reduced. Most often it is
recommended to use more than one method for example FTA and FMEA
(Alverbro et al., 2010).
Figure 2. Failure mode and effects analysis (FMEA table) (Jenkins et al., 2010)
92.3.1 Outsourcing
Majority of the transportation activities of pharmaceutical products is outsourced
(Bishara et al., 2014). For outsourced activity, there must be a written quality
agreement between the parties (GDP, 2013). Quality agreement can be more
than just  a list  of requirements (Bishara et  al.,  2014).   With the help of written
agreement, the roles, responsibilities, requirements, expectations and working
methods are always available and known for both parties. A quality agreement
should be the basis of the partnership and if properly used, it should also make
the partnership stronger.
Good co-operation requires mutual understanding of requirements of both
parties (Bishara et al., 2014). Together with the stakeholders, identification of
the critical process steps and ongoing risk mitigation is essential. Clear and
regular communication between stakeholders, mutually agreed Key Performance
Indicator (KPI) targets and performance monitoring, deviation management, root
cause and corrective and preventive actions (CAPA) follow ups are listed as key
points in good partnership in the pharmaceutical product transportation chain.
2.3.2 Air freight
Though transportation via air freight might be the fastest mode of transportation,
it is a multiphase and complex process (Majic et al., 2016). Air freight process
starts from the shipper’s warehouse, followed by delivery to airport by freight
forwarder, storing the cargo at the terminal, flight to destination airport, storing
at the destination airport and finally freight forwarder delivery to consignee
warehouse (Transco International, Process of Airfreight, 2016). Many different
stakeholders are involved in the handling of the goods at the airport:  including
handling agents, airport warehouse operators and carriers (Majic et al., 2016).
Risks related to air freight are listed in Table 3. The most critical steps in air
freight are the loading and unloading phases, during which there is a significant
risk of temperature excursions and exposure to outside weather conditions. The
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temperature excursions or exposure for weather conditions might also happened
during the delivery from the terminal to the vessel, because aircraft might also
be parked far away from the carriers inbound cargo terminal. Regardless of the
fast transportation time, the goods might be spending relatively long time
waiting in the terminal to be shipped. Long storing times at the terminal makes
the storing time also a critical process step.
Table 3: Risk related to air freight (Majic et al., 2016).
Process step Location Risks Effect of the
risk
Shipment
preparation
Manufacturer Packaging process quality
Shipment documentation
Damage
Delay
Loading
/Unloading
Manufacturer
/transportation
company
/airport
operators
Duration of the loading and
tarmac exposure times
Environmental conditions
Damages
Availability  of  the  shielded
decks
Training of the personnel
Loading sequence (last out
of the controlled storage,
can be the last one loaded
to vehicle)
Temperature
excursion
Damage  of  the
goods
Delays
Transportation
(road)
Transportation
vehicle
Training of the driver
Set point(s) of the container
Availability of proper
vehicle and containers
Cross
contamination
Temperature
excursions
Storage Airport Proper storage conditions
Proper storage area
Training of the personnel
Temperature
excursions
Flight Air Craft Availability of the
temperature controlled
cargo compartments
Temperature
excursions
Due to many risks related to air freight, airlines have lost significant profits to
safer modes of transportation (Majic et al., 2016). In 2014 International Air
Transport Association (IATA) launched a qualification program; Center of
Excellence for Independent Validators (CEIV). Qualification program is
assigned for parties involved with air transportation chain including for example
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airlines, ground handling companies, freight forwarders, road transportation
companies, distributors and airports. The aim of the qualification program is to
offer better compliance towards pharmaceutical industry’s special requirements.
When pharmaceutical companies are selecting partners for air freight, the CEIV
certified companies should be favored.
2.3.3 Ground freight
Like in air transportation, the biggest risks of road transportation are also related
to loading and unloading phases (van Asselt et al, 2015). Other risks related the
transportation via road were: way of loading, which may cause product damage
or issues with temperature control, temperature control during driver´s breaks,
ferry tips or fuel loss. There are also separate risks related to mode of the truck
(mono- or bitemperature trailer). Use of bitemperature trailers requires attention
during the container set point settings and cargo loading order in order to
maintain two different temperature zones in one truck container.  Also separate
risks related to full truck load (FTL) or less than full truck load (LTL) were
identified. Comparison of the risks related to FTL and LTL are listed in Table 4.
Table 4: Comparison of the risks- full truck load vs. less than full truck load (van
Asselt et al, 2015).
Operation Full truck load Less than truck load
Number of pickups One Multiple
Delivery to recipient Direct Via hub/warehouse
Other cargo No other cargo Co-loading from other
shippers
Lead time Short Long
Number of contractors
/subcontractors
Limited Multiple
Risk of temperature
excursions
Low High
Thermotrucks (truck with the reefer/cooling unit) used in transportation of the
pharmaceutical products, should be accompanied with alarm systems (van Asselt
et al, 2015).  The alarm system will send message to the driver in case the
temperature changes outside the set point range or in case the equipment stops
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working. Better planning of the transportation, might enable the companies to
book bi-temperature trailers and also book full truck loads. With full truck load
transportation,  there  is  a  smaller  risk  for  temperature  excursion  due  to  loading
phases,  smaller  risk  for  cross  contamination  from  other  cargo.  In  addition,  the
transportation with full truck load is quicker.
By inspecting the vehicles and containers in advance, many risks can be avoided
(van Asselt et al, 2015). The pre-loading inspection should at least include
checking that the temperature set point(s) are correct, the trailer is visually clean
and free from odor, equipment is working properly and the locks are in place.
The planning of transportation route and pre-check of the suitable appliances
should  be  done  carefully  in  order  to  mitigate  risk  along  the  route.   For
transportation in special conditions, for example, the driver should be prepared
for minor repairs during the transportation if it is known that the condition of
roads  is  poor.  Or  in  case  the  transportation  is  during  winter  or  in  extreme
weather conditions, pre-check-list should include a check of vehicle materials
suitability for extreme temperatures.
Only after the pre-loading inspection is done, the cargo should be loaded into the
trailer (van Asselt et al, 2015). The loading of trailers, must be planned carefully
in order to avoid unnecessary movement of the cargo and allowing free air flow
inside the trailer. In order for the air to flow freely, the pallets must be free from
wrapping from all four sides and pallets cannot be loaded too close to doors.
During transportation the temperature control system should be checked
regularly and the driver should walk around the vehicle after each break, to
ensure that there is no breaking into to trailer and that the alarm and temperature
ranges have been set correctly.
2.3.4. Sea freight
Transportation via sea can be considered the safest mode of transportation
(Edwards, 2017).  Risks related the maritime transportation are mostly related to
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safety  of  the  ships  (Soares  et  al.,   2001).  In  case  of  accidents  in  the  maritime
transportation, the costs of human life, environmental impact, loss of goods and
lost profits are bigger than related to other modes of transportation. The loading
of the sea shipment is done at the consignors’ warehouse (Edwards, 2017). The
container is then sealed until arrival to consignee warehouse. There is a big
difference in the quality of the reefer containers available in different areas. Poor
quality of a reefer container increases the risk of cross contamination and
temperature excursion. It is recommended that the reefer containers should not
be more than 5 year old and shipping lines should provide a pre-trip inspection
form  for  justifying  the  conditions  of  the  reefer  container.  The  use  of  thermal
blankets or passive packing solutions can reduce the risk of temperature changes
during the times the reefer container is out of power. The reefer containers and
its equipment should be a maintained according to manufacturer maintenance.
Also in order to reduce the commercial risks in case of accidents, insurance of
the marine cargo should be in place.
Planning of the sea freight is important (Edwards, 2017). Due to multiple
stakeholders involved in the sea freight, many issues must be discussed well in
advance the actual transportation. It should be agreed when the suitable reefer
containers will be available, pre- tip inspection forms of the containers should be
reviewed and it should be agreed with the transportation company and the port
operators that the container must be transferred into areas with electricity as
soon as possible once container is delivered to port. Risk effects and mitigation
suggestions are presented on Table 5.
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Table 5: Risk effects and mitigation suggestion for risks related to sea freight
(Edwards 2017)
Risk Risk effect Mitigation
Container quality Cross contamination,
temperature excursions
Accept  max  5  year  old
reefer containers
Availability of goods
quality reefer container
Delay Quality agreements,
supplier management
Long delivery time Delay -
Reefer container power Temperature excursion Co-operation with the
stakeholders
2.3.5. Multimodal transportation
Mode of transportation with more than one mode of transportation is called
multimodal transportation (Majic et al., 2016). Example of multimodal
transportation  is  for  example,  air  freight  where  the  goods  are  first  delivered  to
airport with truck, and then cargo is unloaded to terminal storage area, later
loaded into air craft and then back to truck for delivery to customer. Multimodal
transportation is often used in global supply chains (Vilko and Hallikas 2010).
As the multimodal transportation is a combination of different modes of
transportation,  also  risks  related  to  multimodal  transportation  are  more  od  less
the same as the risks related to each mode of transportation separately. Risks
related to multimodal maritime transportation and supply to mainland Finland
are listed in Table 6.  Overall the five biggest risks related to multimodal
transportation in Gulf of Finland were employee strikes in port, fire, ice
conditions and slipperiness in wintertime and information systems. Lack of trust
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and co-operation between the different stakeholders was named as one of the
biggest challenges in multimodal transportation and its risk management.
Table  6  Most  common  risks  related  to  multimodal  transportation  at  Gulf  of
Finland (Vilko and Hallikas 2010).
Risk category Risk (two biggest)
Supply risk Bottle necks on transportation
route, employee strike on port
Operational risk Conditions on cargo handling
equipment, motivation of the
workforce
Security risk Information systems, organized
crime
Macro risk Financial crisis, competition in
transportation sector
Policy risk Russian customs
Environmental risk fire and ice conditions during
wintertime.
2.3.6. Theft
Amount of counterfeit or falsified pharmaceutical products is increasing
(“Falcified Medicinenes” European Medicine Agency: (Reference 14.4.2018)).
Falsified medicinal products reach patients via legal and illegal supply chains
(EU Falsified medicinal directive, 2011). There are big regional differences in
the amounts of falsified or counterfeit products on the market (Abril et al.,
2016). In the developing countries over 30 % of the pharmaceutical market can
be counterfeit or falsified. In the developed countries the amount is
approximately 1%. Counterfeit or substandard medicinal products can be
products that have initially failed the quality requirements (El- Jardali et al
2015). Majority of the illegal drug products are stolen (Riccardi et al., 2014).
Due to increased security in the pharmaceutical facilities, the majority of the
thefts of pharmaceutical products occur during transportation (van Diest et al,
2017). The risk of theft of pharmaceutical products in Europe is relatively low
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(Ekwall et al., 2015). Out of all the recorded cargo theft cases in Europe, Middle
East, and Africa, the theft of pharmaceutical products is only 1%. Risk level of
cargo theft is highly dependent on the route of transportation and risk level
varies highly in different parts of Europe. Even though the risk of theft towards
pharmaceutical products is still overall quite small, the risk in Italy is
significantly higher. In Italy, 9% of all recorded cargo theft cases include
pharmaceutical products. That makes Italy a high risk area for pharmaceutical
product transportation. High number of theft cases for pharmaceutical products,
especially in Southern and Eastern parts of Italy is explained by influence of
Italian Mafia and other criminalized groups on the transportation companies
(Riccardi et al., 2014).  Figure 3 indicates the most risky areas in relation to all
kinds of cargo theft in Europe.
Figure 3. Cargo theft risk map (Van Diest et al., 2017)
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Total 61% of all cargo thefts happen while the vehicle is not moving i.e. vehicle
is parked at truck parks or at the service stations ( International Road Transport
Union (IRU), 2018). The risk of theft from a trailer at unsecured parking lot is
significantly bigger than the risk related to secured parking (Ekwall et al., 2015).
Transportation via road is the most vulnerable for theft (van Diest et al., 2017).
The security of the sea freight is better than of airfreight, because the shipment
container doors are sealed until arrival at consignee warehouse (Edwards, 2017).
In case the seal has been opened during the shipment, it will be noticed latest at
the consignee warehouse. The number of pirate attacks has been decreasing
since 2010 (Statista, 2018). The regions with risk of piracy attacks are Indonesia,
Philippines, Somalia and Nigeria.
The driver has the key role in preventing the crime during transit (van Diest et
al., 2017). The driver should be aware of the high risk areas, know how to
behave in case of incidents and should be given regular security trainings. By
keeping few basic things in mind when planning the transportation route, the
security risks can be reduced by avoiding passing through the high risk areas,
having the breaks at secured parking areas, minimizing the times when the
vehicle is left unattended, preferring using dual drivers, avoiding unnecessary
stops and avoiding driver habits (having break always at the same place etc.). In
order to mitigate the risk of stolen cargo, drivers should identify themselves as
well as show the necessary papers in order to assure that they are authorized for
the transportation (WHO Annex 5, 2010).
There are also security monitoring solutions, CCTV´s or GPS tracking devices
available (van Diest, at al., 2017). The programs monitor the cargo on-line and
immediately report in case of tampering the trailer. GPS tracking and device can
be also combined with temperature monitoring device (“Conventional
Temperature Monitors” Sensitech, Reference 26.4.2018).
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2.3.7 Weather conditions- temperature, humidity
The product stability can be jeopardized during transportation by exposing the
product to environmental conditions such as heat, light and moisture
(Kommanaboyina and Rhodes, 1999). Even though medicinal products should
be transported within their labelled storage conditions, the loading and unloading
phases  might  expose  the  goods  to  outside  temperature  and  weather  conditions
(van Asselt et all, 2017).  Also closing and opening the vehicle doors,
malfunction of the reefer equipment as well as leaks in the transportation
container may expose the product on environmental conditions during transit.
Packaging materials for each pharmaceutical product should be selected and
tested according to guidelines (WHO Annex 9, 2002). The packaging materials
should protect the product from outside conditions (temperature, light and
moisture) that might endanger the products stability. In addition to primary and
secondary packing materials the risk of moisture, light and temperature can be
reduced by for example using active or passive packing systems or other packing
solutions (Rosskoss 2011).   For products requiring close monitoring of the
temperature  conditions,  active  or  passive  solutions  should  be  used.  Table  7
illustrates the differences between active and passive packing solutions.
Table 7: Active and passive packing solutions (Rosskoss 2011).
Active Passive
Needs external power External power not needed
Simple to pack Consignment preparation under
controlled environment
Temperature controlled handling
during transportation required
Temperature specific handling during
transportation is not needed
Costs are the same for bigger and
smaller volumes
Flexible for different volumes
Multi use Mono use
High costs Less costly
For products which are not temperature sensitive, lighter solutions such as
thermal blankets can be used (Basta 2017). The basic idea of the thermal blanket
is to reflect sunlight and provide some extra insulation for the product. Thermal
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blankets are available for different levels of insulation; from slight degree of
insulation to very high degree of insulation against physical and thermal
changes. When selecting the suitable protection for the products few things
should be kept in mind (BioPharm International Editors, 2013). Bigger surface
area absorbs more thermal radiation which means, by increasing the insulation
layer,  the  dimensions  of  the  pallet  are  growing  and  surface  area  grows.  White
color and glossy materials should be favored because it reflects heat radiation
better than dark and matte surface. Metalized covers are bigger risks for
temperature excursion due to materials conductive nature. For example
polyethylene covers could be used instead. The protection against temperature
excursion can be effectively extended by increasing the thermal energy inside
the package. Thermal energy can be increased by using for example gel bags
inside the thermal cover. This way the changes in temperatures inside the
packaging will be significantly slower. For example when 20º C  5ml vial was
placed in a room of 30º C it took 8 minutes for the vial liquid to reach 25º C,
while the same took 10 hours from the same vial to reach 25º C when
surrounded with room temperature gel bag.
A useful tool for evaluations of temperature excursions is the use of Mean
Kinetic  Temperature  (MKT)  (ICH  Q1A  R2).  MKT  is  a  single  calculated
temperature at which the total amount of degradation over a particular time point
is equal to the sum of the individual degradations that would occur at various
temperatures (USP Good Storage and Shipping Practice). Temperature excursion
can be evaluated with the help of MKT- temperature; however the evaluation of
minimum and maximum temperatures is important, too. In case temperature
excursions are out of available stability data, MKT value should not be used as
justification. MKT is higher than the calculated mean temperature, because the
higher temperature values are given greater weight (Equation 1).
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(1)
where ΔH is the heat of activation, which equals 83.144 kJ per mol (default
value; unless more accurate information is available from experimental studies),
R is universal gas constant, which equals 8.3144 x 10-3 kJ per degree per mol,
T1 is the (average) temperature, in degrees Kelvin, during the first time point,
T2 is the (average) temperature, in degrees Kelvin, during the second time point,
Tn is the (average) temperature, in degrees Kelvin, during the nth measured time
point; n being the amount of the measured time points and TK is  the  result  in
degrees Kelvin. The final result MKT (in degree Celsius) will be calculated by
doing simple subtraction (TK – 273.15°K)
In addition to transportation vehicles equipment, temperature and humidity
conditions can be measured for example with the help of dataloggers
(“Conventional Temperature Monitors”, Sensitech. Reference 26.4.2018).  Many
datalogger models can calculate the MKT value automatically.
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3 RISK ASSESSMENT PROJECT
The aim of the project was to conduct a risk assessment for transportation on a
general level to fulfill  EU GDP and GMP Annex 15 Qualification and
validation requirements. The project started by determining the scope. The
selected scope for the risk assessment includes both inbound and outbound
logistics. Inbound logistics include deliveries of raw materials (API ´s and
excipients) and external supply products (bulk and finished product). Outbound
logistics include deliveries to partners and wholesales. Out of risk assessments
scope are the external supply deliveries, where product’s Marketing
Authorization Holder (MAH) is a partner, sample shipments, outbound logistics
where partner is responsible for the transportation, internal transportation
between different plants of the company and courier shipments.
A group of six experts from different areas of expertise were nominated for the
project. Risk assessment project was divided into three workshops. First
workshop was to identify the risks, second to analyze risks and third to evaluate
the risks. As supporting data for risk analysis, company’s transportation
deviation data from 2016 to 2018 was categorized and evaluated.
3.1 Risk identification
Risks were identified with help of fish bone diagram (Ishikawa diagram, Figure
4). All risks mentioned in the risk identification workshop were written down. In
total of 101 risks were identified.
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Figure 4: Fishbone diagram
3.2 Risk analysis
The identified risks were categorized into three different main categories:
General risks, inbound risks and outbound risks. Each main category was then
divided into subcategories. Categorization of the risks is clarified in Table 8.  In
risk analysis, the effects of each risk was further described and current controls
were listed.  Current controls were listed based on the company´s relevant
SOP´s, quality agreements and the knowledge of the expert team.
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Table 8: Categorization of the risks
Risk analysis (categorization of the risks)
General risks
Subcontracting
Accidents
Commercial issues
Inbound risks
Raw materials
External Supply
Road
Air
Sea
Outbound risks
Road
Air
Sea
3.3 Risk evaluation
Risks were analyzed with Failure Mode and Effect Analysis (FMEA) by the
expert team. For each risk, points were given for its severity, occurrence and
detectability. Risk scoring is presented in Table 9.  In case the scoring was not
based  on  the  facts  or  supporting  data,  scoring  was  based  on  the  opinion  of  the
expert team. Company´s transportation deviation data from 2016 to 2018 was
the basis for occurrence scoring.
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Table 9: Scoring of risk severity, occurense and detectability.
Severity
1=  Low  risk  (no  effect  on  the  quality
of the product)
2  =  Medium  risk  (may  have  an  effect
on the quality of the product)
3  =  High  risk  (clear  effect  on  the
quality of the product)
Occurrence
1= Rare (less than once a year)
2= Medium (1-5 times a year)
3= Often (more than 5 times a year)
Detectability
1= always detected or n/a
2= Difficult to detect
3= impossible to detect
Risk point number (RPN) was calculated for each risk by multiplying points of
severity, occurrence and detectability. As a result each risk was categorized as
low risk  (RPN 1-4),  medium risk  (5-8)  or  high  risk  (9-27).  Results  of  the  risk
assessment were presented to Quality Management and Supply Chain
management. Risk mitigation actions were started for risks with high
classification. Residual risks were accepted for the other category risks.
3.4 Results and discussion
The risks were categorized into three category; general, inbound and outbound
logistics. Outsourcing came up with the highest risk points in the general risk
category. Outsourcing was named as high risk operation due to its complexicity
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and difficulty to control. Even though the roles and responbilities must be clearly
described and controlled in the quality agreements, outsourcing can still be
challenging to control (Bishara et al., 2014). Company currently controls
outsourcing in many ways, such as instuctions for goods receive process,
standard operating procedures as well as clear and inclusive agreements with the
wholesalers, partners and subcontractors. With the current controls many of the
risks related to outsourcing can be detected at the company´s warehouse
(inbound logistics) and at the wholesaler warehouse (outbound logistics). For
example, temperature excursions during transportation will be detected once
dataloggers are downloaded at the receiving warehouse, damabed packages will
be detected at the goods receive inspection. The company also arranges regular
meetings with the key suppliers and partners.
Out of all modes of transportation, air freight was detected as the most riskiest
(Majic et al., 2016).  Even though total number of identified risks related to air
freight is lower than with road transportation, more high level risk were
identified  in  air  freight.  Majority  of  the  risks  of  air  freight  were  related  to
temperature control, divided deliveries or mixups. Due to complexicity of the air
freight chain, it was identified as extremely challenging to control.
Both sea and air freight are strictly controlled, thus less risky for crime, unlike
road  transportation.  The  number  of  security  related  risks  were  highest  on  road
transportation. Road transportation is the only mode of transportation in which
only the driver is responsible for the safety of the cargo (van Diest et al., 2017).
Road transportation is also vulnerable for other risks such as mixups during
loading and unloading phases and other external risks (for example addition of
prohibited materials into shipping container etc.). The review of company´s
deviation data from 2016-2018 also reflects the safety issues of the road
transportation. Deviations were recoded during two years review period where
the truck had been broken in or prohibited products delivered in the same
containers space with the medicinal products. No such deviations were recorded
neither for air freight, nor sea freight.
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Sea freight was detected as the least risky mode of transportation (Edwards,
2017). Sea shipment containers are sealed at the consignors warehouse and seals
cannot be opened during the transportation. Due to that fact, shipment container
are well protected against crime or temperature deviations. However, in case of
any defect during the sea freight, the amount and value of cargo affected is
usually bigger than with other modes of transportation.
There were no major differences between inbound and outbound risks. The
difference between inbound and outbound logistics is the company´s role. On
the inbound logistics the company works as the receiving site and on the
outbound logicstics the company´s role is the consignee. The risks related to
each mode of transportation were the same regardless of the inbound or
outbound logistics standpoint.
Total amount of identified risks per each category are presented in Table 10.
Risks are categorized as per the risk classification as well as total number of
risks.
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Table 10: Risk assessment results (number of risks identified)
INBOUND (number of risks)
LOW MEDIUM HIGH Total
General 2 0 1 3
Raw
materials
10 1 1 12
Road 14 9 1 24
Air 13 0 5 18
Sea 14 1 0 15
OUTBOUND (number of risks)
LOW MEDIUM HIGH TOTAL
General 2 0 2 4
Road 18 7 1 26
Air 12 2 4 18
Sea 15 0 0 15
The risk assessment project results are in line with the literature review. Overall
in the risk assessment project, quite many identified risks were already
controlled by the company´s current risk mamagement process. In such cases,
eventhough the severity of such risk was given high points, most often the
detectability was then given low points, because, with current controls, the
defects are always or very often noticed with company´s standard process.
3.5. Conclusions
Complex transportation chains, multiple modes of transportation and changes in
the outside weather conditions make the control challenging. Both risk
assessment  results  as  well  as  literature  review  conclude  that  overall  the  air
freight is the  most riskiest mode of transportation. Especially, the tarmac phase
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of the air freight causes temperature deviations and lack of control at the airport
causes divided deliveries.
The outcome of the risk assessment project as well as the literature review is in
line with copany´s current experience of the risks related to transportation of
medicinal products. The results of the risk analysis also confirm that the
company´s current controls are effective in preventing and detecting the possible
deviations  in  the  transportation.   The  risk  assessment  project  also  revealed  the
areas which required further improvements, i.e. recidual risks. Detailed plan for
recidual risk mitigation was also issued and presented to the management team.
Currently there is a lack of independent studies regarding transportation of
medicinal  products.  However,  because  risk  assessment  of  transportation  is  a
GMP requirement, the pharmaceutical companies might have issued the studies
internally.
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